LiVeritas Biosciences, Inc. Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
LiVeritas Biosciences, Inc. is a biotechnology research company based in South San Francisco, California. It supports biopharma developers by leveraging mass spectrometry data and digital workflows to accelerate drug research and development. The company provides curated analytical test packages designed to move drug candidates forward, covering drug design optimization, process development and characterization, and speeding the path to Investigational New Drug (IND) submission. In addition, LiVeritas offers software solutions that streamline analytical operations, CMC strategies, and the management of drug product knowledge, backed by industry expertise drawn from biotech startup environments and big-pharma competencies. A notable recent development is the July 2023 beta launch of the LiLii platform, described as a next-generation, fully integrated laboratory ecosystem for drug development.